Active ingredientGefapixantCat. No. P-G020-001CAS 1015787-98-0Family · Pharmaceutical analytical standards
Gefapixant
A P2X3 receptor antagonist that blocks the ATP signals linked to hypersensitivity of the cough nerves; approved in Japan in 2022 for refractory or unexplained chronic cough. This family brings together the active ingredient and other impurities.
Did you know?It also blocks the P2X2/3 receptor, an important mediator of taste perception: this is why its most frequent side effects concern taste.
Go to the active ingredient →Active ingredientGefapixantCat. No. P-G020-001CAS 1015787-98-0
ImpurityGefapixant Impurity 1Cat. No. P-G020-002CAS 865304-71-8
ImpurityGefapixant Impurity 2Cat. No. P-G020-003
ImpurityGefapixant Impurity 3Cat. No. P-G020-004
ImpurityGefapixant Impurity 4Cat. No. P-G020-005
ImpurityGefapixant Impurity 5Cat. No. P-G020-006
ImpurityGefapixant Impurity 6Cat. No. P-G020-007CAS 2413718-92-8
ImpurityGefapixant Impurity 7Cat. No. P-G020-008
ImpurityGefapixant Impurity 8Cat. No. P-G020-009
ImpurityGefapixant Impurity 9Cat. No. P-G020-010
ImpurityGefapixant Impurity 10Cat. No. P-G020-011
ImpurityGefapixant Impurity 11Cat. No. P-G020-012CAS 2527107-23-7
ImpurityGefapixant Impurity 12Cat. No. P-G020-013CAS 2527107-24-8
ImpurityGefapixant Impurity 13Cat. No. P-G020-014No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.